ClinConnect ClinConnect Logo
Search / Trial NCT06804525

LHC-CIDI-5 in Hong Kong

Launched by THE UNIVERSITY OF HONG KONG · Jan 27, 2025

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Life History Calendar Cidi Recall Bias Retrospective Reporting Lifetime Prevalence Mental Disorders

ClinConnect Summary

This clinical trial is looking at a new tool called the life history calendar (LHC) to help improve the way we assess mental health disorders in Hong Kong. The LHC is designed to assist people in recalling important life events, which can make it easier to accurately report experiences with mental health issues. By combining this tool with a standard questionnaire known as the CIDI-5, researchers hope to better identify conditions like depression, anxiety, and substance use disorders compared to using the questionnaire alone.

To participate in this study, individuals must be at least 25 years old, have lived in Hong Kong for at least six months in the past year, and be able to read and communicate in Chinese or English. If you decide to join, you can expect to answer questions about your mental health and life experiences in a supportive environment. This trial aims to ensure that mental health assessments are more precise, which can lead to better understanding and treatment options for those in need.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All household members aged 25 years old and over are randomly sampled from the Census and Statistics Department List of Quarters
  • Live in the address sampled from the Census and Statistics Department List of Quarters
  • Reside in Hong Kong for at least six months in the past year
  • Able to read and communicate in Chinese or English
  • Without linguistic or cognitive difficulties
  • Exclusion Criteria:
  • Domestic workers

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, Sar, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Michael Y. Ni, MD

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported